Docusign vs. Monday.com: Absolute Scale vs. Faster Growth in Tech Revenues
Key Points
Docusign generates a higher overall revenue total than monday.com, maintaining a clear advantage by leading the comparison across all eight reported quarters.
Both organizations displayed steady quarter-over-quarter revenue increases throughout the observed timeframe, though the smaller business maintained a noticeably steeper growth trajectory.
Investors should watch whether the absolute revenue gap between the two companies continues to slowly widen or if the differing growth rates eventually begin to close that distance.
- 10 stocks we like better than Docusign ›
Docusign: Generating Steady and Consistent Revenue Growth
Docusign Inc. (NASDAQ:DOCU) primarily earns revenue by providing electronic signature software and digital agreement management tools to global businesses.
It recently launched its intelligent agreement platform natively within the Salesforce.com Inc. (NYSE:CRM) ecosystem and reached an agreement to sell these solutions to SAP SE (NYSE:SAP) customers.
Monday.com: Sustaining Rapid and Uninterrupted Revenue Expansion
Monday.com (NASDAQ:MNDY) generates revenue by providing a cloud-based visual work operating system for building custom enterprise management applications.
While undergoing a management flattening process that led to five senior executive departures, it launched a new voice-based artificial intelligence agent platform for enterprise sales teams.
Why Revenue Matters for Investors
Revenue here refers to the data provider's standardized income statement revenue line item and indicates whether a business is successfully attracting and retaining paying customers.
Docusign vs. Monday.com Revenue over the last 8 quarters.
Quarterly Revenue Performance for Docusign and Monday.com
| Calendar quarter | Docusign Revenue | Monday.com Revenue |
|---|---|---|
| Q3 2024 | $754.8 million (quarter ended Oct. 31, 2024) | $251.0 million (quarter ended Sept. 30, 2024) |
| Q4 2024 | $776.3 million (quarter ended Jan. 31, 2025) | $268.0 million (quarter ended Dec. 31, 2024) |
| Q1 2025 | $763.7 million (quarter ended April 30, 2025) | $282.3 million (quarter ended March 31, 2025) |
| Q2 2025 | $800.6 million (quarter ended July 31, 2025) | $299.0 million (quarter ended June 30, 2025) |
| Q3 2025 | $818.4 million (quarter ended Oct. 31, 2025) | $316.9 million (quarter ended Sept. 30, 2025) |
| Q4 2025 | $836.9 million (quarter ended Jan. 31, 2026) | $333.9 million (quarter ended Dec. 31, 2025) |
| Q1 2026 | $830.2 million (quarter ended April 30, 2026) | $351.3 million (quarter ended March 31, 2026) |
| Q2 2026 | $875.7 million (quarter ended July 31, 2026) | $364.6 million (quarter ended June 30, 2026) |
Foolish Take
Normally, the first thing to note when examining a company's revenue trend is seasonality: some times of the year have stronger buying patterns than others. For most stocks, compare revenue year over year, by quarter. Tech stocks are not known for having strong seasonality, but it exists nonetheless for some businesses. Docusign, for instance, sees seasonality because there are more agreements and documents signed in the fourth quarter of the calendar year. Monday.com's seasonality is less dramatic, with some shifts seen as the calendar year turns and corporate budgets reset.
Even with the existence of seasonality for both businesses, this chart shows little effect on the growth of the businesses. The upwardly trending bars left to right indicate that each company is growing revenue at a healthy clip, offsetting any quarterly variation. For Docusign, sales in its current fiscal year are seen growing by nearly 9% to $3.5 billion, with a slightly better percentage gain in net income to $346 million. For Monday.com, its full-year sales should rise nearly 20% to $1.47 billion, but net income should weaken to about $68 million.
Revenue is perhaps the simplest metric investors have to judge a business by. As the chart shows, look for rising revenue, especially over similar periods of each year, and take comparable-quarter stagnation, or worse, declines, as a red flag.
Data source: Financial Modeling Prep. Data as of Nov. 2, 2026.
Should you buy stock in Docusign right now?
Before you buy stock in Docusign, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Docusign wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $341,966!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,146,819!*
Now, it’s worth noting Stock Advisor’s total average return is 852% — a market-crushing outperformance compared to 203% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of November 7, 2026.
Brendan Coffey has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Docusign, Monday.com, and Salesforce. The Motley Fool has a disclosure policy.
Recommended Articles
